Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK5 | Q00535 | 1/20 | 0.36 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.36 |
| ▸ | WNT3A | P56704 | 1/20 | 0.36 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.36 |
| ▸ | IKBKB | O14920 | 1/20 | 0.35 |
| ▸ | CDC7 | O00311 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
| ▸ | TDO2 | P48775 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.30 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16503585 | 0.82 | MEN1 (0.42) | TNKS2 | |
| SCHEMBL562413 | 0.82 | MAPK13 (0.43) | — | |
| SCHEMBL563038 | 0.76 | NOX1 (0.48) | — | |
| SCHEMBL563130 | 0.76 | MAPT (0.46) | — | |
| SCHEMBL563212 | 0.75 | WNT3A (0.35) | CDK5CDK5R1WNT3ATNKS2IKBKB | |
| SCHEMBL10049931 | 0.74 | CDK5 (0.34) | CDK5CDK5R1WNT3ATNKS2IKBKB | |
| SCHEMBL563044 | 0.65 | ADORA3 (0.31) | — | |
| SCHEMBL14060157 | 0.65 | MAPK13 (0.64) | — | |
| SCHEMBL562125 | 0.65 | PNP (0.42) | — | |
| SCHEMBL563259 | 0.64 | RAB9A (0.42) | BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8815846-B2 | Family of antichagasics derived from imidazo[4,5-C][1,2,6]thiadiazine 2,2-dioxide | UNIVERSIDAD DE LA REPUBLICA DE URUGUAY (UY) | 2014-08-26 | — | — | US | claimed |
| US-20120035160-A1 | NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE | UNIVERSIDAD DE LA REPUB'LICA URUGUAY (UY) | 2012-02-09 | — | — | US | claimed |
| EP-2392577-A1 | NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE | Consejo Superior de Investigaciones Científicas (CSIC) (ES) | 2011-12-07 | — | — | EP | claimed |
| US-8815846-B2 | Family of antichagasics derived from imidazo[4,5-C][1,2,6]thiadiazine 2,2-dioxide | UNIVERSIDAD DE LA REPUBLICA DE URUGUAY (UY) | 2014-08-26 | — | — | US | disclosed |
| US-8815846-B2 | Family of antichagasics derived from imidazo[4,5-C][1,2,6]thiadiazine 2,2-dioxide | UNIVERSIDAD DE LA REPUBLICA DE URUGUAY (UY) | 2014-08-26 | — | — | US | disclosed |
| US-20120035160-A1 | NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE | UNIVERSIDAD DE LA REPUB'LICA URUGUAY (UY) | 2012-02-09 | — | — | US | disclosed |
| US-20120035160-A1 | NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE | UNIVERSIDAD DE LA REPUB'LICA URUGUAY (UY) | 2012-02-09 | — | — | US | disclosed |
| EP-2392577-A1 | NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE | Consejo Superior de Investigaciones Científicas (CSIC) (ES) | 2011-12-07 | — | — | EP | disclosed |
| EP-2392577-A1 | NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE | Consejo Superior de Investigaciones Científicas (CSIC) (ES) | 2011-12-07 | — | — | EP | disclosed |
| WO-2010086481-A1 | NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) | 2010-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035160-A1 | NEW FAMILY OF ANTICHAGASICS DERIVED FROM IMIDAZO[4,5-C][1,2,6]THIADIAZINE 2,2-DIOXIDE | THOC2, TUBGCP2, TBC1D5 | CDK5 993/4885CDK5R1 924/4885WNT3A 4114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.